Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026
Facebook X (Twitter) Instagram
Trending
  • Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore
  • Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027
  • India’s DeepTech Capital Needs People Who Can Put It to Work
  • Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput
  • Bench Mark Infotech Services Limited Reports H1 FY27 Results
  • Raise Money Ventures Lights Up Noida’s Startup Ecosystem with a Festive Diwali Networking Celebration
  • After the Success Of His memoir ‘One Fine Day’, Author Sameer Bhide Embarks On His Second Book
  • Global Schools Group Opens Applications for its fully-funded Global Citizen Scholarship 2027
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Health»From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage
Health

From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage

Arjun SinghBy Arjun SinghMay 16, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage

Geneva [Switzerland], May 16: In a proud moment for India, Naman Gosalia’s consistent advocacy for making cardiovascular prevention the default, not optional, is now bringing India-born AnginaX into global healthcare and public-health conversations alongside presidents of leading cardiology societies, global healthcare leaders, policymakers, institutions, and international public-health stakeholders from across the world.

His growing voice on prevention-first healthcare has led to invitations to discussions at World Heart Federation forums and broader health-policy conversations aligned with the United Nations ecosystem, where the future of cardiovascular prevention is increasingly becoming a global priority.

For decades, healthcare systems around the world have largely focused on treating heart attacks after they happen.

Naman Gosalia believes the future of healthcare will be defined by something far more important: preventing them before they begin. That belief is now taking India-born AnginaX onto the global stage.

At a time when cardiovascular disease claims nearly 18 million lives annually worldwide, according to the World Health Organization, Gosalia has become a leading advocate for moving healthcare earlier, before symptoms, before emergencies, and before patients reach catastrophic stages of disease.

As the Founder of AnginaX, he is leading a prevention-first cardiovascular model that integrates advanced medical science, precise preventive pathways, and intelligent systems into a single, continuous approach to lifelong cardiovascular health.

The objective is ambitious but deeply human: to ensure people do not enter healthcare for the first time only after a crisis begins.

During a recent podcast conversation on GunjanShouts, Gosalia summarized the philosophy behind the movement:

“Our fight is against the disease. We don’t want to save lives only at the ICU; we want to protect lives much earlier, while people are still at home.”

His advocacy is increasingly resonating across clinicians, hospitals, policymakers, and public-health stakeholders exploring how prevention can become a continuous layer integrated into routine healthcare delivery at a real population scale.

Through AnginaX, Gosalia has brought together cardiologists, physicians, scientists, researchers, engineers, and technologists around one mission: shifting healthcare from reactive treatment toward continuous cardiovascular health building.

Rather than positioning prevention as occasional screening, the vision focuses on enabling earlier awareness and action before cardiovascular disease progresses toward angina, heart attack, stroke, or catastrophic events.

Healthcare systems globally continue to face rising chronic disease burden, increasing emergency care costs, and overwhelmed infrastructures. In that environment, prevention is no longer being viewed as a future aspiration.

It is increasingly becoming a necessity.

For many across India, this represents a proud moment, an Indian-born prevention vision beginning to influence how the world approaches cardiovascular health at a population scale.

And while the conversations around AnginaX continue to expand internationally, Gosalia’s central message remains remarkably clear:

“The future of healthcare will not be defined by how well we treat heart attacks; but by how effectively we prevent them.”

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Continued vigilance is essential to protect India’s polio-free status

November 17, 2026

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

November 16, 2026

Aayush Wellness Launches Himalayan Shilajit Drops as Global Shilajit Market is Projected to Reach USD 436.72 Million by 2034, Growing at 8.67% CAGR

November 16, 2026

Comments are closed.

Top Posts

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Finance

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

By Arjun SinghNovember 17, 2026

Dehradun (Uttarakhand) [India], November 17: Neetu Yoshi Limited (BSE: 544434), a leading manufacturer of customised…

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026

Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput

November 17, 2026
Most Popular

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026

Type above and press Enter to search. Press Esc to cancel.